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A systematic quantitative analysis of temporal
changes in host and viral proteins throughout the
course of a productive infection could provide
dynamic insights into virus-host interaction. We
developed a proteomic technique called ‘‘quanti-
tative temporal viromics’’ (QTV), which employs
multiplexed tandem-mass-tag-based mass spec-
trometry. Human cytomegalovirus (HCMV) is not
only an important pathogen but a paradigm of viral
immune evasion. QTV detailed how HCMV orches-
trates the expression of >8,000 cellular proteins,
including 1,200 cell-surface proteins to manipulate
signaling pathways and counterintrinsic, innate,
and adaptive immune defenses. QTV predicted natu-
ral killer and T cell ligands, as well as 29 viral proteins
present at the cell surface, potential therapeutic tar-
gets. Temporal profiles of >80% of HCMV canonical
genes and 14 noncanonical HCMV open reading
frames were defined. QTV is a powerful method
that can yield important insights into viral infection
and is applicable to any virus with a robust in vitro
model.
INTRODUCTION
Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus
that persistently infects the majority of the world’s population
(Mocarski et al., 2013). Following primary infection, HCMV
persists for the lifetime of the host under the control of a healthy
immune system (Nichols et al., 2002). Reactivation from viral
latency to productive infection in immunocompromised indi-
viduals, and acquisition of primary infection in utero or during
transplantation can lead to serious disease (Mocarski et al.,
2013).With the possibility of CMV being used as a vaccine vector
(Hansen et al., 2013), a complete understanding of its ability to
modulate host immunity is paramount.1460 Cell 157, 1460–1472, June 5, 2014 ª2014 The AuthorsDuring productive infection, HCMV gene expression
is conventionally divided into immediate-early (IE), early (E),
and late (L) phases. The IE2 gene is primarily responsible
for activating transcription of early-phase genes. By definition,
early genes encode functions necessary to initiate viral
DNA replication. Early-late genes (E-L) are initially transcribed
at low levels and upregulated after the onset of viral DNA
replication, whereas true-late genes are expressed exclusively
after DNA replication and include proteins required for the
assembly and morphogenesis of HCMV virions (Mocarski
et al., 2013).
HCMV is a paradigm for viral immune evasion that perturbs
the interferon (IFN) response (Powers et al., 2008), suppresses
antigen presentation through the efficient downregulation of
MHC class I (van der Wal et al., 2002), and has eight or more
genes that act to suppress natural killer (NK) cell function
(Wilkinson et al., 2008). Nevertheless, our understanding of
how HCMV evades and modulates intrinsic immune sensors
and effectors during infection remains superficial. It is not known
which viral proteins are present at the cell surface, or how viral
and host proteins are regulated during infection. Prior analysis
of the temporal expression of HCMV genes has relied either on
semiquantitative immunoblots of single viral proteins, or micro-
arrays, which cannot capture posttranscriptional change (Ma
et al., 2012). Although 604 noncanonical HCMV open reading
frames (ORFs) have been identified by ribosomal footprinting
(Stern-Ginossar et al., 2012), it is not yet clear howmany of these
ORFs encode functional polypeptides. Answering such ques-
tions has the potential to reveal mechanisms of immune evasion,
cell-surface drug targets, and an improved understanding of
HCMV biology.
In this paper, we describe a proteomic approach to study
viral infection (quantitative temporal viromics, QTV), based onpre-
cise temporal quantitation of plasma membrane (PM) and intra-
cellular proteins. We combined plasma membrane profiling, our
recently described method for isolation of highly purified PM pro-
teins for proteomic analysis (Weekes et al., 2012), with study of
whole-cell lysates (WCL). We quantified proteins from up to ten
samples using isobaric chemical tags (tandem mass tags, TMT)
(McAlister et al., 2012) and MS3 mass spectrometry. This utilizes
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Figure 1. Temporal Plasma Membrane Profiling of HCMV-Infected Fibroblasts
(A) Workflow of experiments PM1 and WCL1.
(B) Hierarchical cluster analysis of all proteins quantified in experiment PM1 and annotated ‘‘plasma membrane,’’ ‘‘cell surface,’’ ‘‘extracellular,’’ or ‘‘short GO’’
(Figure S1A).
(C) All ABC transporters quantified. One-way ANOVA with multiple hypothesis correction: *p < 0.005, **p < 0.0001.
(D) Quantitation of all HCMV proteins reported present at the surface of infected fibroblasts. gB, gH, gL, gO, and UL132 are virion envelope glycoproteins
expressed late in infection. One-way ANOVA with multiple hypothesis correction: *p < 0.005, **p < 0.0001.
(E) Principal component analysis of all quantified proteins from experiments PM1 and WCL1 confirmed that biological replicates were highly reproducible and
suggested that the major source of variability within a given experiment was duration of infection.
(F) Correlation between proteins quantified in experiments PM1 and PM2.
See also Figure S1 and Table S1.two consecutive peptide fragmentation steps to liberate TMT
reporters, minimizing interference from coisolated ions and
enabling uniquely precise quantitative measurement of protein
abundances at a near-global proteomic scale (Ting et al., 2011).
We quantified >8,000 proteins including 1,184 cell-surface pro-
teins and 81% of all canonical HCMV proteins over eight time
points during productive infection, providing a near-complete
temporal view of the host proteome and HCMV virome. Quantita-
tive temporal viromics provides a framework for the study of any
virus, enabling in-depth analysis of key aspects of viral
pathogenesis.RESULTS
Validation of Quantitative Temporal Viromics
We infectedprimary human fetal foreskin fibroblasts (HFFFs) with
HCMV strain Merlin and initially used 8-plex TMT to quantify
changes in PM protein expression. We assessed in biological
duplicate three of the reference time points in productive HCMV
infection and mock infection (experiment ‘‘PM1’’, Figure 1A).
We quantified 927 PMproteins (Figure S1A available online). Sur-
prisingly, 56% of proteins changed >2-fold and 33% >3-fold by
72 hr of infection. Replicates clustered tightly (Figure 1B).Cell 157, 1460–1472, June 5, 2014 ª2014 The Authors 1461
We previously demonstrated that HCMV protein UL138 de-
grades the cell-surface ABC transporter Multidrug Resistance-
associated Protein-1 (ABCC1) in both productive and latent
infections and showed that the ABCC1-specific cytotoxic sub-
strate Vincristine could be used therapeutically to eliminate cells
latently infected with HCMV (Weekes et al., 2013). To validate
findings in this present study of productive infection, we exam-
ined all quantified ABC transporters and found selective downre-
gulation of ABCC1 as well as ABCC3 (Figure 1C). The ABCC3
drug transporter might represent an additional therapeutic
target.
We further validated our results by comparison to all PM pro-
teins that exhibit reported changes during productive HCMV
infection in fibroblasts. We observed expected changes in 21/
22 cellular proteins (Table S1A; Figure S1B) and detected six
of six previously reportedHCMVproteins at the PM. Five of these
are virion envelope glycoproteins expressed late in infection
(Figure 1D).
Temporal analysis of whole-cell lysates (WCLs) of HCMV-
infected HFFFs enables the study of changes in expression
of all proteins during infection and a comparison of the total
abundance of a given protein to its expression at the PM.
By analyzing WCL of HFFF infected simultaneously with PM
samples, we again saw a high degree of reproducibility
among biological replicates (experiment WCL1, Figures 1E
and S1C) and confirmed changes in 31/35 previously reported
proteins (Table S1B). We further validated our findings by
comparison to a high-throughput western blot analysis
of cells infected with Toledo strain of HCMV (Stanton
et al., 2007) and saw a strong association between protein
changes in both experiments (p < 0.0001, Fisher’s exact
test, Table S1C).
QTV to Screen for Antiviral Factors and Interferon-
Induced Genes
To gain a more detailed view of changes in the host cell prote-
ome and HCMV virome over the course of a productive infection,
and to focus on events early in infection such as the IFN
response, we used 10-plex TMT (McAlister et al., 2012). We
analyzed productively infected HFFFs at seven time points,
plus a duplicate mock infection (Figure S1D). For the tenth sam-
ple, we analyzed 12 hr infection with irradiated virus, in which
viral DNA is inactivated, allowing for infection but preventing viral
gene expression (Sullivan et al., 1971). Comparison of early pro-
ductive infection and infection with irradiated virus allowed us to
dissect the contribution of the virion to changes in the cellular
proteome.
We quantified 1,184 PM proteins (experiment PM2, Fig-
ure S1E) and 7,491 cellular proteins (experiment WCL2, Fig-
ure 2A). Protein temporal profiles correlated well between repeat
time courses (Figures 1F and S1F). Data from all four experi-
ments are shown in Table S2, where the worksheet ‘‘Plots’’ is
interactive, enabling generation of overlayed temporal graphs
of PMandWCL expression of any of the human and viral proteins
quantified.
Antiviral IFN effects are conferred by interferon-stimulated
gene (ISG) products that target different stages of virus replica-
tion and include known herpesvirus restriction factors Viperin1462 Cell 157, 1460–1472, June 5, 2014 ª2014 The Authorsand IFI16 (Gariano et al., 2012). HCMV infection triggers
expression of ISG, which the virus counters by impairing the
IFN signaling pathway, degrading the double-stranded RNA
sensor RIG-I (Retinoic acid-inducible gene I) and ‘‘repurpos-
ing’’ ISGs such as Tetherin to enhance rather than restrict viral
replication (reviewed in Amsler et al., 2013). The temporal
effects of these strategies on ISG protein expression are poorly
understood as are the HCMV proteins responsible, although
the immediate early proteins IE1 and IE2 and the apoptosis
inhibitory protein vMIA have been implicated (Amsler et al.,
2013).
One cluster of 40 proteins from experiment WCL2 (cluster A)
exhibited striking upregulation at 6 and 12 hr after infection, fol-
lowed by rapid return to near-basal levels (Figures 2A and 2B).
Fourteen were viral proteins, and 26/40 were human, of which
85% are already known to be interferon responsive. Seventy-
three percent of these proteins are additionally known to have
antiviral function (Table S3A).
We therefore performed a comprehensive search of all other
known interferon-induced antiviral genes, to determine which
might be similarly or otherwise modulated during HCMV infec-
tion (Duggal and Emerman, 2012; Schoggins et al., 2011). Our
results were consistent with the reported degradation of RIG-I
and of the nuclear HCMV restriction factor Sp100 during infec-
tion (Figures 2A and S2A, respectively) (Kim et al., 2011a;
Scott, 2009). Many of the tripartite motif-containing proteins
(TRIMs) are interferon induced. TRIM5a can restrict HIV,
although no viral factor is yet known to antagonize its expres-
sion (Rahm and Telenti, 2012). We quantified 21 TRIMs, of
which TRIM 5, 16, 22, and 38 were downregulated during
infection (Figure S2B). SAM Domain and HD Domain 1
(SAMHD1), zinc finger CCCH-type, antiviral 1 (ZAP/ZC3HAV1),
and the novel anti-HIV factor Schlafen 11 (SLFN11) behaved
similarly to members of cluster A (Figure S2A). It remains to
be determined whether any of these antiviral proteins can
restrict HCMV, and if reduction in their expression simply re-
flects diminished IFN signaling and response, or selective tar-
geting by virus.
The relative contribution to ISG expression of active HCMV
transcription (sensed, for example, by RIG-I) and viral binding
to pattern recognition receptors (such as Toll-like receptor 2) is
poorly understood (Paludan et al., 2011). We identified a group
of 84 proteins significantly upregulated during productive infec-
tion, of which only 20% were >2-fold upregulated by irradiated
virus (Figure 2C; Table S3B). The 84 proteins include 25/26
human proteins from cluster A, and 39% are known to be upre-
gulated by IFN. Transcriptionally active HCMV may thus play an
important role in ISG induction.
QTV Identifies Down- or Upregulated Signaling
Pathways
The activity of a signaling pathway can be modulated either by
posttranslational modification, or regulation of expression of a
pathway member. Changes in protein expression can be quan-
tified by QTV. We have shown that after an initial activation,
the expression of ISG is rapidly reduced during HCMV infection,
but how is this achieved? We quantified 13/15 key members of
IFN induction and signaling pathways (Figure 3A, reviewed in
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Figure 2. Temporal WCL Analysis of HCMV-Infected Fibroblasts Demonstrates Exquisite Regulation of ISGs
(A) Hierarchical cluster analysis of all proteins quantified in experiment WCL2, and enlargement of the top cluster A that included multiple IFN-induced antiviral
proteins. Right panels, example temporal profiles. The y axis shows relative abundance of each protein. Red diamonds, 12 hr after infection with irradiated HCMV.
(B) Immunoblots of HFFF infected with HCMV confirm proteomic profiles.
(C) Interferon-induced proteins were more potently upregulated by productive infection than infection with irradiated HCMV. For each protein, signal:noise from
the 12 hr irradiated virus or productive infection samples, and bothmock samples was normalized to 1. The order of samplesmock 1 andmock 2was randomized
into mock (a) and mock (b). The difference in normalized signal:noise was then calculated as indicated, and histograms were plotted. Where <0.05% of proteins
were upregulated by infection with irradiated virus, 2% of proteins were upregulated by infection with live virus. These included 69 viral proteins and 84 human
proteins, of which 39% are known ISGs.
See also Figure S2 and Table S3.Amsler et al., 2013). We confirmed known effects of HCMV infec-
tion on Jak1, STAT2, and IRF9 (Le et al., 2008) and demonstrated
that, apart from STAT1, expression of the final effectors in both
interferon induction and response pathways were all progres-sively diminished during infection (Figure 3A). An effect of
HCMV infection on IRF3 has not previously been reported.
The k-means method is useful to cluster proteins into a spec-
ified number of classes based on the similarity of temporalCell 157, 1460–1472, June 5, 2014 ª2014 The Authors 1463
AB C
Figure 3. Modulation of Intracellular
Signaling Pathways during HCMV Infection
(A) Quantitation of interferon induction and
response pathways. The temporal profile of each
protein is shown over 96 hr of infection, and
colored red (downregulation), blue (unchanged), or
green (upregulation). Data were derived from
experimentWCL2 apart from IFNAR1 and IFNAR2,
from PM2. Expression of certain ISGs is known to
occur in the absence of IFN, in an IRF3-dependent
manner. PRR, pattern recognition receptors.
(B) Average temporal profiles from 3-class
k-means clustering of proteins quantified in ex-
periments WCL2 and PM2. The three classes
divided proteins into downregulated (red), un-
changed (blue), or upregulated (green).
(C) Enrichment of KEGG pathways within each
class was determined using DAVID software,
against a background of all quantified proteins.
Benjamini-Hochberg adjusted p values are shown
for each indicated bar (*p < 0.00001, **p < 0.0001,
***p < 0.01, ****p < 0.05). Individual pathways are
shown in Figures S3A–S3C, and pathway mem-
bers are shown in Table S4.profiles. We clustered all 7,491 proteins from experiment WCL2
and 1,184 proteins from PM2 into three classes (corresponding
to upregulation, downregulation, and no change) to identify novel
pathways dysregulated during HCMV infection (Figure 3B). We
then applied DAVID software (Huang et al., 2009) to determine
which KEGG (Kyoto Encyclopedia of Genes andGenomes) path-
ways were enriched in each class (Figures 3C and S3A). We
made the discovery that multiple members of the TLR signaling
pathwaywere downregulated (Figures S3A and S3B; Table S4A),
suggesting that HCMV might employ a number of strategies to
avoid this intrinsic immune mechanism. Fatty acid metabolism
and oxidative phosphorylation were upregulated during infection
(Figure 3C; Table S4A), corresponding to published literature
(Koyuncu et al., 2013).
A lack of gap junction intercellular communication is common
in cancer, and is thought to enable escape of homeostatic
control. Gap junction alpha-1 protein (GJA1) modulates the
expression of many genes involved in cell-cycle control and
tumorigenesis and is degraded by HCMV IE1 and IE2
(Khan et al., 2014; Stanton et al., 2007). We confirmed GJA11464 Cell 157, 1460–1472, June 5, 2014 ª2014 The Authorsdownregulation and found multiple other
members of the gap junction signaling
pathway similarly changed (Figure S3B;
Table S4A).
The KEGG pathways ‘‘colorectal can-
cer’’ and ‘‘pathways in cancer’’ were en-
riched in the downregulated PM cluster
and included Frizzled receptors FZD1, 2,
4, 6, and 7 and signaling protein WNT5a,
all key members of the wnt pathway. We
additionally discovered downregulation
of the canonical wnt pathway corecep-
tors LRP5 and 6, and of noncanonical re-
ceptors ROR1, ROR2, RYK, and PTK7.
Overall, 11/13 quantified wnt receptors were downmodulated
(Figure S3D). Diminished transcription of wnt target genes and
increased degradation of the key wnt mediator b-catenin have
been reported in HCMV infection; however, the underlying
mechanism is unclear (Angelova et al., 2012). Our discovery of
downregulation of the majority of all wnt receptors suggests
that diminished basal signaling from the cell surface may lead
to increased proteasomal b-catenin degradation. Multiple
effects on different cell-surface receptors suggest that the mod-
ulation of this signaling pathway may be of paramount impor-
tance to HCMV.
In order to expand our search, we performed gene set enrich-
ment analysis (GSEA) based on the average k-means profiles for
up-and downregulated WCL clusters (Figure 3B) (Subramanian
et al., 2005). GSEA can increase the power to detect enrichment
because it scores pathways based on similarity of protein
members to a prototypic profile, as opposed to determining
enrichment within a large group of proteins with broadly similar
profiles. Multiple mitochondrial metabolic and biosynthetic path-
ways were significantly upregulated and confirmed the changes
AB
C
D
Figure 4. Temporal Changes in Known and Putative Cell-Surface Immunomodulators
(A) Temporal profiles of known NK ligands whose modulation by HCMV had not previously been recognized.
(B) Temporal profiles of T cell ligands not previously known to be modulated during infection.
(C) Temporal profiles of all quantified protocadherins.
(D) Validation of the temporal profile of PDCHgC3 by flow cytometry.
Red diamonds, 12 hr after infection with irradiated HCMV. See also Figure S4, Table S5, and Data S1.we observed in fatty acid metabolism and oxidative phosphory-
lation. Transcription and export of mRNA was upregulated.
Downregulated pathways included Robo receptor signaling,
important in cell proliferation andmotility, and ERBB and VEGFR
signaling (Table S4B).
Discovery of NK and TCell Ligands and Families of Other
Cell-Surface Receptors/Ligands Modulated by HCMV
Infection
We mined our data for all known NK cell ligands (Vivier et al.,
2008) and discovered previously unrecognized modulation of
six ligands during HCMV infection. E-cadherin (CDH1), the ligand
for the inhibitory NK receptor KLRG-1 (killer cell lectin-like recep-
tor subfamily G member 1), was dramatically upregulated during
infection. Vascular cell adhesion molecule 1 (VCAM1) and B7-
H6, ligands for activating NK receptors a4b1 integrin and
NKp30, were downregulated (Figure 4A). Interestingly, other
known ligands including collagen I (COL1A1 and COL1A2),
collagen III (COL3A1), cell adhesion molecule-1 (CADM1), and
poliovirus receptor-related 1 (PVRL1) were expressed in a
manner that would be expected for an appropriate response to
intracellular infection (Figure 4A; Table S2).
We performed a similar screen for all known ab T cell costimu-
latory molecules, and gd T cell ligands (Bonneville et al., 2010;
Hubo et al., 2013). The T cell costimulators ICOSLG (inducible
T cell costimulator ligand) and PD-L2 were downregulated
during infection, as was butyrophilin subfamily 3 member A1
(BTN3A1), recently shown to present phosphoantigens toVg9Vd2+ T cells (Vavassori et al., 2013). V-domain Ig suppressor
of T cell activation (VISTA, C10Orf54), a novel B7 family inhibitory
ligand (Ceeraz et al., 2013) was upregulated late in infection
(Figure 4B).
NK and T cell ligands belong to a few key protein families,
including cadherins, C-type lectins, immunoglobulin, TNF recep-
tor, and major histocompatibility-complex-related molecules
(Vivier et al., 2008). In order to discover immunomodulating
proteins, we added InterPro functional domain annotations to
data from experiments PM1 and PM2 (Hunter et al., 2012) and
reasoned that modulation of a ligand during HCMV infection
may indicate biological importance. Seventy-four proteins
had a relevant InterPro annotation and at least a 4-fold change
compared to mock infection (Table S5A; Data S1). Eight down-
regulated proteins were protocadherins. Examining all quantified
proteins in this family, we found that six of six g-protocadherins
were particularly potently downregulated (Figure 4C). The
protocadherins may therefore represent a major set of
immunomodulators.
We confirmed temporal profiles of protocadherins PCDHgC3
and FAT1 in addition to eight other cell-surface proteins by
flow cytometry and immunoblot (Figures 4D and S4A, S4C,
and S4E). To provide proof-of-principle validation of our func-
tional predictions, we performed siRNA-mediated knockdown
of the C-type lectin CLEC1A (Table S5A), which is downregu-
lated 7-fold by HCMV and is a potential NK ligand by homology
to CLEC2D. Polyclonal NK-cells from three of three independent
donors demonstrated reduced degranulation to autologousCell 157, 1460–1472, June 5, 2014 ª2014 The Authors 1465
targets upon knockdown of CLEC1A suggesting that this mole-
cule may be a novel activating NK ligand (Figure S4D). We
observed similar results for the protocadherin FAT1, providing
initial confirmatory evidence that members of this family may
indeed be involved in immunoregulation (Figure S4E). CEA-
CAM-1 (immunoglobulin family) was upregulated 20-fold by
HCMV infection and may have roles in T cell regulation. Using
a blocking antibody, we demonstrated increased degranulation
of CD8+ T cells specific for an HCMV HLA-A2 restricted peptide
epitope suggesting that upregulation of this molecule in infected
cells may inhibit cytotoxic T cell-mediated lysis (Figure S4F).
There is increasing evidence for a substantial role of plexin-
semaphorin signaling in the immune system (Takamatsu and Ku-
manogoh, 2012). For example, secreted class III semapohrins
bind plexins A and D1 to regulate migration of dendritic cells
to secondary lymphoid organs. Plexin B2 interacts with mem-
brane-bound semaphorin 4D to promote epidermal gd T cell
activation (Witherden et al., 2012). HCMV infection substantially
downregulated five of the nine plexins: A1, A3, B1, B2, and D1.
Intriguingly, neuropilin 2, a plexin coreceptor was also rapidly
downregulated. Semaphorin 4D was dramatically upregulated
and 4C downregulated, suggesting that viral interaction with
these ligands is complex (Table S5A; Data S1).
To determine which protein domains and biological processes
were enriched within highly downregulated PM proteins, we
used DAVID software (Huang et al., 2009). The Interpro cate-
gories ‘‘protocadherin gamma’’ and ‘‘immunoglobulin-like fold’’
were significantly enriched in addition to Gene Ontology (GO)
biological processes ‘‘regulation of leukocyte activation’’ and
‘‘positive regulation of cell motion,’’ suggesting a negative effect
of HCMV on cell motility. DAVID analysis also revealed families of
downregulated proteins, including six G-protein-coupled recep-
tors from the rhodopsin-like superfamily (Table S5B).
Within the category ‘‘regulation of leukocyte activation,’’
ephrin B1 was downregulated, and we therefore examined all
ephrins and their receptors. We observed striking downregula-
tion of ephrins B1 and B2 as well as all three of their quantified
B-class ephrin receptors (Data S1). Downstream effects of
forward or reverse ephrin signaling include changes in cell adhe-
sion, shape, and motility, and there is evidence for a role of
ephrin B2 in murine T cell costimulation (Nikolov et al., 2013),
suggesting that downregulation of this pathway may represent
another mechanism of immune evasion.
Temporal Analysis of HCMV Viral Protein Expression
Most prior studies of the temporal expression of canonical
HCMV proteins have employed immunoblots at only one or a
few time points. Comparison between different reports has
been complicated by lack of specific antibodies and study-to-
study variation in the HCMV strain used, with laboratory-adapted
strains AD169 and Towne (which lack a large number of ORFs
as a result of extensive passage in vitro) often used in preference
to isolates containing a complete genome (Ma et al., 2012).
We were able to quantify the temporal expression of the majority
(139/171) of the canonical HCMV proteins as well as 14 non-
canonical ORFs; most of these proteins were quantified in a
single experiment (Figure 5, plots for all quantified viral proteins
in Data S1).1466 Cell 157, 1460–1472, June 5, 2014 ª2014 The AuthorsIE/E/E-L/L cascades are functionally defined by the use of
metabolic inhibitors. IE transcripts accumulate in the presence
of a protein synthesis inhibitor such as cycloheximide. Expres-
sion of early genes is unaffected by viral DNA synthesis inhibitors
such as Phosphonoformate (PFA), whereas E-L genes are
partially inhibited, and L genes completely inhibited (Chambers
et al., 1999).
A complementary method of classification would be to group
viral proteins according to their temporal profiles. Use of the
k-meansmethodwith four classes suggested that HCMVprotein
profiles grouped similarly to the recognized functional cascades
IE/E/E-L/L (Figure 5A). We performed k-means clustering with 2
to 14 classes and assessed the summed distance of each
protein from its cluster centroid. Although this summed distance
necessarily becomes smaller as more clusters are added, the
rate of decline decreases with each added group, eventually
settling at a fairly constant rate of decline that reflects overfitting;
clusters added prior to this point reflect underlying structure in
the temporal protein data, whereas clusters subsequently added
through overfitting are not informative. The point of inflexion fell
between five and seven classes, suggesting that there are at
least five distinct temporal protein (Tp) profiles of viral protein
expression (Figures 5A–5D). We term these classes Tp1, Tp2,
Tp3, Tp4, and Tp5. There was generally good correspondence
between classical functional and protein temporal classes, for
example, the known L proteins UL99, UL94, UL75, UL115, and
UL32 all classified as Tp5 (Omoto andMocarski, 2014). A cluster
of 13 proteins that we call Tp4 exhibited a distinct profile to Tp3
and Tp5, with maximal expression at 48 hr and low expression at
other time points (Figures 5C and 5D). Members of this cluster
predominantly originated from two regions of the viral genome
(Table S6A).
To directly compare classical functional and protein temporal
classes, we performedWCL analysis in the presence or absence
of the viral DNA replication inhibitor PFA (experiment WCL3, Fig-
ures 5C and 5D; Table S2; plots for all quantified viral proteins
in Data S1). Expression of 48/55 Tp5-class proteins was
completely or almost completely inhibited by PFA. Tp3 and
Tp4 proteins were generally partially inhibited, with little
effect on Tp1 or Tp2. Some proteins displayed more complex
profiles, with enhanced expression later in infection with PFA
block (Data S1).
Eight proteins appear earlier in infection than had previously
been understood. UL27, UL29, UL135, UL138, US2, US11,
US23, and US24 all exhibited peak expression at 6–18 hr after
infection (Figure 5C). UL29 and US24 appeared particularly
early, with peak expression at only 6 hr postinfection, which
may correspond with their suggested ability to stimulate IE
gene expression (Feng et al., 2006; Terhune et al., 2010).
We were unable to confidently resolve the profile of UL122
(IE2). UL122 and UL123 are expressed by alternative splicing
of a single major immediate-early transcript. Exons 1, 2, 3, and
4 encode UL123 and exons 1, 2, 3, and 5 encode UL122; how-
ever, additional transcripts have also been detected from the
region of exon 5 (Stenberg et al., 1989; Stern-Ginossar et al.,
2012). We examined each peptide quantified from every exon
(Figure S5A). The profiles of all peptides from exon 4 peaked at
18–24 hr, corresponding to the predicted expression of UL123
A B
C
D
Figure 5. Definition of Temporal Classes of HCMV Gene Expression
(A) The k-meansmethod was used to cluster all quantified HCMV proteins (experimentWCL2) into four or five classes. Shown are the average temporal profiles of
each class. With four classes, proteins grouped into classes similar to the classical IE/E/E-L/L cascades. With five classes, a distinct temporal profile appeared
(blue).
(B) Number of temporal classes of HCMV gene expression. The summed distance of each protein from its cluster centroid was calculated for one to 14 classes
and plotted. The point of inflexion fell between five and seven classes.
(C) Top: temporal profiles of proteins in each k-means class (experiment WCL2) were subjected to hierarchical clustering by Euclidian distance. Both UL112 and
isoform p50 of UL112 (UL112-2) were quantified. UL122 was excluded from clustering due to uncertainty in peptide assignment. Bottom: experiment WCL3. Viral
protein profiles were further assessed in the presence or absence of the viral DNA replication inhibitor PFA. Proteins are displayed in the same order as the
clusters defined in the upper panels.
(D) Temporal profiles of typical proteins from each cluster (upper panel), and the corresponding profiles in the presence or absence of PFA (lower panel).
See also Figure S5, Table S6, and Data S1.protein. The profiles of ten exon 5 peptides corresponding to the
late-expressed internal ORF, ORFL265C.iORF1 (Stern-Ginossar
et al., 2012) peaked at 96 hr. A single peptide N-terminal to this
ORF that is likely to originate from UL122 had a distinct profile
with expression from 6 hr that peaked at 48 hr, similar to
UL122 mRNA (Stern-Ginossar et al., 2012). This suggests the
existence of at least two proteins arising wholly or in part from
exon 5 and corresponds to the detection of an abundant late
40 kDa protein, previously detected from the same internal
exon 5 ORF of AD169 strain (Stenberg et al., 1989). It is likelythat ORFL265C.iORF1 protein is more abundant than UL122,
effectively masking the earlier signal from most UL122 exon 5
peptides. Our quantitation of DNA polymerase processivity sub-
unit UL44 may similarly have been complicated due to multiple
transcription start sites (Data S1).
We further compared our protein-level data with recent RNA-
sequencing-based temporal analysis of HCMV Merlin strain
transcripts at 5, 24, and 72 hr postinfection in HFFF (Stern-Gi-
nossar et al., 2012). We again used 5 k-means classes to group
transcripts based on their temporal profiles (Figure S5C).Cell 157, 1460–1472, June 5, 2014 ª2014 The Authors 1467
Because there were no intermediate mRNA time points between
5 and 24 hr, or between 24 and 72 hr, there was insufficient infor-
mation to make an accurate comparison between the central
three mRNA clusters and our Tp2, Tp3, or Tp4 class proteins.
We therefore used mRNA data to define three classes: Tr1,
Tr2–4, and Tr5 (Figure S5C). Comparison to our protein data
was striking: 10/13 Tp1 proteins were also Tr1 transcripts and
49/55 Tp5 proteins were Tr5 transcripts (p < 0.0001, Fisher’s
exact test) (Table S6C; Figure S5D). Such correspondence be-
tween different studies targeting distinct classes of biomolecules
suggests that the temporal classes of HCMV gene expression
we define are likely to be biologically relevant.
We quantified the full temporal profiles of nine noncanonical
HCMV ORFs. Four ORFs related to canonical HCMV proteins
(N-terminal extension, internal ORF, C-terminal extension) and
demonstrated similar temporal profiles to their canonical coun-
terparts (Figure S5B; Data S1). Five ORFs were encoded either
in different reading frames, or on the reverse strand to canonical
genes (Table S6B). We additionally quantified five further nonca-
nonical ORFs in experiment WCL3 (Data S1).
HCMV Proteins Present at the Cell Surface
Viral proteins present at the surface of an infected cell may be
therapeutic antibody targets. To date, only six HCMV proteins
have been demonstrated at the PM of infected fibroblasts, all
late in infection, which we have confirmed (Figure 1D). Several
other studies transduced individual viral genes and de-
monstrated protein appearance at the cell surface, which can
indicate but may not reflect protein location during productive
infection (Table S7).
We detected a total of 67 viral proteins in experiments PM1
and PM2. Plasma membrane profiling provides a very substan-
tial enrichment for PM glycoproteins (up to 90% of proteins
from unfractionated samples, and approximately 60% of pro-
teins from fractionated samples have indicative Gene Ontology
(GO) terms (Figure S1A) (Weekes et al., 2012). Subcellular local-
ization of viral proteins is, however, poorly annotated, making it
difficult to determine which might be non-PM contaminants,
such as abundant viral tegument and nuclear proteins.We there-
fore developed a filtering strategy: for every GO-annotated
human protein quantified in experiment PM1 or PM2 (Fig-
ure S1A), we calculated the ratio of peptides (experiments
PM1 + PM2)/(experiments WCL1+WCL2). Ninety-two percent
of proteins that were GO-defined non-PM had a ratio of <1.4;
88% of human proteins scoring above 1.4 were annotated as
PM proteins, demonstrating the predictive value of this metric
(Figure 6A). Applying this filter, we defined 29 high-confidence
viral PM proteins, which included the majority of viral proteins
previously identified at the surface of either infected or trans-
duced cells, and excluded all proteins unlikely to be present at
the cell surface based on their known function (Table S7).
In general, we observed a striking correlation between the
PM2 and WCL2 temporal profiles of all 29 high-confidence pro-
teins. For the subset of known virion envelope glycoproteins
(Varnum et al., 2004), protein expression at the PM was signifi-
cantly later than in WCL, confirmed by analysis of the same pro-
teins from experiments PM1 andWCL1 (Figures 6B and S6). This
may reflect assembly of the HCMV virion within the viral cyto-1468 Cell 157, 1460–1472, June 5, 2014 ª2014 The Authorsplasmic assembly compartment prior to viral egress (Alwine,
2012) and demonstrates that QTV can additionally provide in-
sights into aspects of the viral life cycle. PM appearance of
UL119 was similarly delayed, suggesting that this known virion
glycoprotein may be a component of the virion envelope. The
sensitivity of MS3 TMT-based mass spectrometry is suggested
by our apparent quantitation of binding or fusion of viral envelope
with the plasma membrane; there was a small early peak in PM
presence of most virion envelope glycoproteins at 6 hr of infec-
tion that disappeared by 12 hr (Figure 6B).
QTV Indicates Mechanism of Action of Viral Proteins
We have previously shown that HCMV UL141 retains the polio-
virus receptor (PVR) in the endoplasmic reticulum, inhibiting
cell-surface expression and preventing interaction with acti-
vating NK receptor DNAM-1. Intracellular PVR accumulates
during HCMV infection. In contrast, a second DNAM-1 ligand
poliovirus receptor-related 2 (PVRL2) is targeted for proteasomal
degradation by UL141 acting with other HCMV gene(s) (Prod’-
homme et al., 2010; Tomasec et al., 2005). QTV confirmed these
results; we observed rapid depletion of PVR from the plasma
membrane, in contrast to its accumulation within WCL. PVRL2
was lost from both PM and WCLs (Figure 7). The WCL kinetics
of UL141 expression paralleled that of PVR but were inversely
related to PVRL2.
The activating receptor NKG2D is expressed on a variety of
immune effector cells and recognizes major histocompatibility
complex class I-related ligands MICA, MICB, and ULBP1-3.
HCMV infection strongly induces transcription of MICB,
ULBP1, and ULBP2mRNA but prevents their surface expression
by intracellular sequestration with HCMV UL16 (Dunn et al.,
2003a). Our data were highly consistent with this literature. Inter-
estingly, cell-surface expression of ULBP1 and -2 rose late in
infection, suggesting that UL16 had become overwhelmed
(Figure 7A).
We therefore examined other HCMV proteins known to target
cell-surface receptors (Table S1A). The profiles of UL138 and
ABCC1 were consistent with their codegradation (Weekes
et al., 2013), and the profile of HLA-A reflected US2 and US11-
mediated degradation (Figure 7B). Other examples are shown
in Figures S7A and S7B. The temporal profiles provided by
QTV are thus useful to gain mechanistic insights into known in-
teractions between viral and host proteins.
DISCUSSION
In this study, we provide a comprehensive resource describing
temporal changes in viral and host proteomes during infection
with HCMV. Simultaneous study of protein expression at the
cell surface and in whole-cell lysates has revealed insights into
many aspects of the viral life cycle. To be able to persist in an
infected individual lifelong, herpesviruses have developed a
wealth of strategies to modulate innate and adaptive immunity.
One benefit is that we can use HCMV infection to discover pro-
teins important in host defense, as viral modulation of protein
expression generally reflects biological imperative. We often
observed modulation of multiple members of the same protein
family, increasing the likelihood of biological relevance; for
A B
Figure 6. HCMV Proteins Quantified at the Surface of Infected Fibroblasts
(A) Histogram of peptide ratios for all GO-annotated proteins quantified in experiments PM1 or PM2. ‘‘PM only,’’ not detected in experimentsWCL1 orWCL2. ‘‘PM
annotation’’: ‘‘plasma membrane’’, ‘‘cell surface,’’ ‘‘extracellular,’’ or ‘‘short GO.’’
(B) Temporal profiles of all high-confidence PM proteins (Table S6). Virion envelope glycoproteins were generally detected significantly earlier in whole-cell
lysates than in plasma membrane samples. Arrows, quantitation of fusion or binding of the virion envelope and the plasma membrane.
See also Figure S6 and Table S7.example, six of six g-protocadherins that are downregulated
during infectionmay be novel NK ligands in addition to protocad-
herin FAT1. The correspondence in temporal profiles of proteins
in cluster A (Figure 2A) enables prediction of IFN-stimulated
genes, which might additionally have antiviral function. Multiple
signaling pathways were modulated by HCMV, which has the
potential to inform not only viral interaction networks by predict-
ing effects on pathway target genes but improves our knowledge
of the metabolic changes necessary to effect viral replication
(Koyuncu et al., 2013). GSEA provides a particularly useful over-
view of many of the pathways and receptors changing signifi-
cantly in our data.
The temporal quantitation of >80% of canonical HCMV pro-
teins in one experiment provides a significant technical advance.
Our knowledge of HCMV protein profiles has so far relied on a
literature complicated by the use of multiple different labora-
tory-adapted viral strains, different cell types, and variable infec-
tion conditions (Ma et al., 2012). Many have not previously been
quantified. We provide a temporal system of classification ofHCMV protein expression using the prototype clinical strain
Merlin, which is complementary to and consistent with the func-
tionally derived classical IE/E/E-L/L nomenclature. For example,
expression of 87% of proteins we define as Tp5 was prevented
by the viral DNA replication inhibitor PFA. These data suggest
that the classical ‘‘true late’’ category of transcripts could be
substantially expanded. Furthermore, all capsid proteins we
quantified (Mocarski et al., 2013) belonged to class Tp5, whereas
viral tegument proteins were more diverse: of 27 quantified,
three were Tp1, 2 Tp2, 8 Tp3, and 14 Tp5, suggesting that these
proteins may additionally have nonstructural roles such as regu-
lation of gene expression and immune evasion. It remains to be
seen whether Tp4 proteins have a distinct function that requires
peak expression at 48 hr of infection, for example, preparation of
the cell for virus release via inhibition of neutralizing antibody and
cellular immunity (RL11 family), or promoting viral egress and
cell-cell spread (Table S5A). Particular advantages to our tempo-
ral measurements include the ability to correlate viral and cellular
protein expression, narrowing the field of viral proteins possiblyCell 157, 1460–1472, June 5, 2014 ª2014 The Authors 1469
A B
Figure 7. QTV Provides Mechanistic Insights into Downregulated Cell-Surface Targets
(A) Proteins that are known to be sequestered within the cell accumulated in WCL samples during infection.
(B) Proteins targeted for lysosomal or proteasomal degradation declined during infection.
Red diamonds, 12 hr after infection with irradiated HCMV. See also Figures S7A and S7B.responsible for target modulation and in some cases indicating
mechanism. The utility of QTV could be extended by simulta-
neous transcriptomic studies; if a host protein is downregulated,
is this due to diminished gene expression, or posttranscriptional
effects such as protein degradation?
In their recent ribosomal profiling (RP) analysis of HCMV,
Stern-Ginossar et al. (2012) identified 147/171 canonical genes.
We quantified 139/171 proteins (Table S2), notably including 15
genes not detected by RP. Proteins UL1 and UL6 were quanti-
fied at the PM but not in WCL samples suggesting that overall
abundance of both mRNA and protein might be low. It is unclear
why RP failed to detect the 13 remaining proteins, which in
several cases we quantified by abundant peptides. It is likely
that the sensitivity of QTV for low-abundant proteins will be
further increased with the next generation of Orbitrap mass
spectrometers, enabling an evenmore comprehensive coverage
of both HCMV and human proteomes. For example, analysis of
experiment WCL3 using the new Orbitrap Fusion enabled
quantitation of five noncanonical ORFs we previously did not
detect. Even with this sensitive instrument, it is still possible
that wewere unable to detect very low-abundant proteins, which
may explain why some studies have detected viral transcripts
earlier in infection that our protein measurements suggest. An
increase in proteome coverage will also improve our ability to
distinguish protein isoforms, which complicated our quantitation
of UL122.
With an increasing frequency of transplantation and emer-
gence of drug resistance, novel strategies are required to treat
HCMV infection. QTV provides evidence for up to 29 cell-surface
viral glycoproteins that can now be assessed as targets for ther-
apeutic monoclonal or bispecific antibodies, to stimulate anti-
body-dependent cellular cytotoxicity or deliver a cytotoxin.
Strongly upregulated PM proteins may constitute alternative1470 Cell 157, 1460–1472, June 5, 2014 ª2014 The Authorsantibody targets. By directing treatment toward proteins ex-
pressed early in infection, it may be possible to eliminate infected
cells prior to the release of infectious virus. The efficacy and
safety of such an approach is suggested by small-scale treat-
ment of patients with severe drug-resistant HCMV disease using
pooled immunoglobulin selected for high antibody titers to
HCMV (Alexander et al., 2010). QTV has demonstrated great util-
ity in being able to identify and quantify the regulation of virus and
host proteins on the cell surface without requirement for specific
antibodies. Clearly, the cell-surface viral proteins we describe
require validation using an independent approach once reagents
are available.
QTV is applicable to any virus, or indeed any intracellular path-
ogenwith a robust in vitromodel and has the potential to improve
our understanding of infection.
EXPERIMENTAL PROCEDURES
Brief descriptions of key experimental procedures are provided below. For
complete details, see Extended Experimental Procedures.
Virus Infections
Twenty-four hours prior to each infection, 1.5 3 107 HFFFs were plated in
a 150 cm2 flask. Cells were sequentially infected at multiplicity of infection
10 with HCMV strain Merlin. Greater than 95% of cells were routinely
infected using this approach (Figures S4A and S4B). Infections were
staggered such that all flasks were harvested simultaneously. For 12 hr
irradiated virus infection, virus was gamma irradiated with a dose of
3,500 Gy.
Protein Isolation and Peptide Labeling with Tandem Mass Tags
Plasma membrane profiling was performed as described previously (Weekes
et al., 2012). One hundred percent of each peptide sample was labeled with
TMT reagent, and six fractions were generated from combined peptide sam-
ples by tip-based strong cation exchange. For whole-proteome analysis, cells
were lysed and protein was reduced and then alkylated. Protein was digested
with LysC (experiment 1) or LysC and then Trypsin (experiments 2 and 3). Pep-
tides were labeled with TMT reagent, and 12 fractions were generated by high-
pH reverse-phase HPLC.
Mass Spectrometry and Data Analysis
We performed mass spectrometry using an Orbitrap Elite (experiments 1 and
2) or an Orbitrap Fusion (experiment WCL3) and quantified TMT reporter ions
from the MS3 scan (McAlister et al., 2012; Ting et al., 2011). Peptides were
identified and quantified using a Sequest-based in-house software pipeline.
A combined database was searched, consisting of (1) human Uniprot, (2)
Merlin strain HCMV Uniprot, and (3) all additional noncanonical HCMV ORFs
(Stern-Ginossar et al., 2012). Peptide-spectral matches were filtered to a 1%
false discovery rate (FDR) using linear discriminant analysis in conjunction
with the target-decoy method (Huttlin et al., 2010). The resulting data set
was further collapsed to a final protein-level FDR of 1%. Protein assembly
was guided by principles of parsimony. Where all PSM from a given HCMV
protein could be explained either by a canonical gene or noncanonical ORF,
the canonical genewas picked in preference. Proteinswere quantified by sum-
ming TMT reporter ion counts across all matching PSM after filtering based on
isolation specificity (Pease et al., 2013). Reverse and contaminant proteins
were removed, and protein quantitation values were exported for normaliza-
tion and further analysis in Excel. Hierarchical clustering was performed using
centroid linkage with Pearson correlation unless otherwise noted. One-way
ANOVA was used to identify proteins differentially expressed over time in
experiments PM1 and WCL1, and p values were corrected for multiple testing
using the method of Benjamini-Hochberg. Other statistical analysis was per-
formed using XLStat.
NK and T Cell CD107a Mobilization Assays
NK and T cell degranulation assays were performed in a similar manner to that
described previously (Prod’homme et al., 2010). These protocols were
approved by the Cardiff University School of Medicine Ethics Committee
Ref. no: 10/20.
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